Xu et al. reported that methamphetamine exposure disrupts insulin signaling, leading to brain insulin resistance, as evidenced by the downregulation of insulin receptor substrate-1 and AKT serine 473, along with activation of GSK-3β [35]. This evidence concerns the gene AKT1 and Insulin resistance.